MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ultragenyx Pharmaceutical (RARE) Ownership - Who owns Ultragenyx Pharmaceutical?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.15B
P/E Ratio
N/A
Total Cash
621.61M
Projected Growth
N/A
Total Debt
34.08M
Revenue
522.75M
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash/Share
6.73
Total Debt/Equity
N/A
Revenue/Share
6.01 USD as % of share price
Fundamentals
RARE
Capitalization
4.15B
P/E Ratio
N/A
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash
622M
Total Cash/Share
6.73
Total Debt
34.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.01%
Revenue
523M
ROE
N/A
Book Value
347M
P/B Ratio
11.96
Cash Flow
N/A
Earnings
-6.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
92K
Current Ratio
2.81
Current Revenue Per Employee
109321.32
Dividends Per Share - Security
N/A
EBITDA
-461.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
84.93
Revenue To Assets
-40.27
Shares Held By Institutions
10.2B
Shares Outstanding - Current
92.3M
Total Liabilities
1.19B
Total Volume MTD
N/A
Value
-1
Gain YTD
-6.002
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com